What C-Suite Pharma Talent Needs to Look Like in 2025
Biopharma is leaping forward. AI is designing molecules. Blockbuster obesity drugs are rewriting revenue expectations. Even regulatory shifts are coming faster than the next product cycle. There’s a lot going on, and it’s forcing every leader to rethink pricing, investment, […]